Taro Pharmaceutical

Taro Pharmaceutical is owned by Sun Pharma.

Sun Pharma is one of the...

• Forbes Global 2000 (#1578);
• Nifty 500.

Sun Pharma is a company listed under the stock ticker SUNPHARMA (IN).

Sun Pharma has a direct presence in 2 countries.

Sun Pharma has 4 subsidiaries including Chattem Chemicals, Natco Pharma and Sun Pharma USA.

They are in:

• Pharmaceuticals80%
• Chemicals20%

Acquisition, funding and merger involving Sun Pharma.

• Sun Pharma has announced the acquisition of Taro Pharmaceutical  (posted on January 18 2024).

View the org chart displaying its 25 main executives

Most searched biographies at Taro Pharmaceutical

• Uday Baldota, Chief Executive Officer and Director
• James Kedrowski, Director
• Linda Benshoshan, Director

Popular executive movements at Sun Pharma

• Sailesh Desai, Executive Director, is retiring  (posted on April 7 2024).
• Dheeraj Sinha has joined the company as Executive Vice President and Chief Information Officer  (posted on April 5 2024).
• Suresh Kumar Rai has joined the company as Senior Vice President and Chief Human Resources Officer  (posted on December 8 2023).

Create your alert
to follow the executive moves at Taro Pharmaceutical.

Sun Pharma has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Taro Pharmaceutical

• Taro Provides Results for the Quarter Ended June 30, 2022 | Taro Pharmaceutical
• Taro to Release First Quarter Results on July 27, 2022 | Taro Pharmaceutical
• Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 | Taro Pharmaceutical
• Taro Provides Results for the Year Ended March 31, 2022 | Taro Pharmaceutical
• News Releases | Taro Pharmaceutical
• Taro to Announce Full Year Results on May 26, 2022 | Taro Pharmaceutical
• Taro Completes Acquisition of Alchemee | Taro Pharmaceutical
• Taro to Acquire Alchemee From Galderma | Taro Pharmaceutical
• Taro Provides Results for December 31, 2021 | Taro Pharmaceutical
• Taro to Announce Third Quarter Results on January 27, 2022 | Taro Pharmaceutical
• View more press releases Close

Social media about Taro Pharmaceutical

• Taro Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Taro Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Uday Baldota

Call Taro Pharmaceutical at +1 914...

View the org chart

Register to receive your alert

Report an error